Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

ISIS 2503 in Treating Patients With Advanced Cancer of the Pancreas

This study has been completed.
National Cancer Institute (NCI)
Ionis Pharmaceuticals, Inc.
Information provided by:
University of Alabama at Birmingham Identifier:
First received: May 2, 2000
Last updated: December 30, 2010
Last verified: December 2010
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Primary Completion Date: December 2000 (Final data collection date for primary outcome measure)